Franklin Resources Inc. Takes $139,000 Position in Inogen, Inc. (NASDAQ:INGN)

Franklin Resources Inc. acquired a new stake in Inogen, Inc. (NASDAQ:INGN) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 15,188 shares of the medical technology company’s stock, valued at approximately $139,000. Franklin Resources Inc. owned 0.06% of Inogen at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Meeder Asset Management Inc. acquired a new position in Inogen during the 2nd quarter worth about $30,000. Quarry LP acquired a new position in shares of Inogen in the third quarter worth approximately $59,000. Verition Fund Management LLC bought a new stake in Inogen in the third quarter valued at approximately $106,000. Virtu Financial LLC acquired a new stake in Inogen during the 3rd quarter valued at approximately $111,000. Finally, Paloma Partners Management Co bought a new position in Inogen during the 3rd quarter worth approximately $126,000. Institutional investors own 89.94% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on INGN. StockNews.com lowered Inogen from a “buy” rating to a “hold” rating in a research report on Friday, December 20th. Needham & Company LLC reissued a “hold” rating on shares of Inogen in a research note on Friday, November 8th.

Inogen Stock Up 0.2 %

Shares of INGN stock opened at $9.19 on Friday. The firm has a market cap of $218.89 million, a P/E ratio of -4.08 and a beta of 1.02. The company has a 50 day moving average of $9.38 and a 200-day moving average of $9.76. Inogen, Inc. has a 12-month low of $5.08 and a 12-month high of $13.33.

Inogen Company Profile

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.